Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: A pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP)

Clinical and Applied Thrombosis/Hemostasis

Volumn 13, Issue 3, 2007, Pages 241-248

  Pengo, Vittorio ^a,g   Palareti, Gualtiero ^b   Cucchini, Umberto ^a   Molinatti, Maurizio ^c   Del Bono, Roberto ^d   Baudo, Franco ^e   Ghirarduzzi, Angelo ^f   Pegoraro, Cinzia ^a   Iliceto, Sabino ^h  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MARIA VITTORIA HOSPITAL   (Italy)

^d Brescia Hospital   (Italy)

^e Division of Hematology Niguarda ca'Granda   (Italy)

^f Reggio Emilia Hospital   (Italy)

^g UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^h NONE

Author keywords

Bleeding; Prostheses; Stroke; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CARDIOASPIRIN; HEPARIN; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EMBOLISM; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMOPERICARDIUM; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOEMBOLISM; VASCULAR DEATH;

AGED; ANTICOAGULANTS; AORTIC VALVE; ASPIRIN; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MITRAL VALVE; PILOT PROJECTS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; WARFARIN;

EID: 34347248017     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607302544     Document Type: Article

References (29)

1. Edmunds LH Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987 ; 44: 430.
2. Stein PD, Kantrowitz A. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest 1989 ; 95 (suppl 2). 107.
3. Fuster V., Badimon L., Badimon JJ, Chesebro J. Prevention of thromboembolism induced by prosthetic valves. Semin Thromb Hemost 1988 ; 14: 50.
4. Guidelines on Oral Anticoagulation: ed. 2. The British Society for Haematology. J Clin Pathol 1990 ; 43: 177.
5. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995 ; 333: 11.
6. Saour JN, Sieck JO, Mamo Lar, Gallus AS Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990 ; 322: 428.
7. Altman R., Rouvier J., Gurfinkel E., et al. Comparison of two levels of anticoagulant theraoy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991 ; 101: 327.
8. Stein PD, Alpert JS, Copeland J., et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992 ; 102 (suppl 4). 445.
9. Acar J., Iung B., Boissel JP, et al. AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996 ; 94 (9). 2107.
10. Wilson DB, Dunn MI, Hassanein K. Low-intensity anticoagulation in mechanical cardiac prosthetic valves. Chest 1991 ; 100: 1553.
11. Arnesen PV, Aagaard J. Low-dose warfarin in patients with Carbomedics heart valve prostheses. Asian Cardiovasc Thorac Ann 2000 ; 8: 11.
12. Kuntze Cee, Ebels T., Eijgelaar A., van der Heide JNH. Rates of thromboembolism with three different mechanical heart valve prostheses: Randomized study. Lancet 1989 ; 19: 514.
13. Turpie Agg, Gent M., Laupacis A., et al. A comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement. N Engl J Med 1993 ; 329: 524.
14. Pengo V., Barbero F., Banzato A., et al. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prosthesis. Thromb Haemost 1977 ; 77: 839.
15. Italian Federation of Anticoagulation Clinics (FCSA). A guide to oral anticoagulant treatment. Haematologica 2003 ; 88 (suppl 2). 1.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 ; 53: 457.
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966 ; 50: 163.
18. Sahai H., Kurshid A. Statistics in Epidemiology: Methods, techniques and applications. CRC Press, Boca Raton, FL ; 1996.
19. Rosendaal FR, Cannegieter SC, van der Meer Fjm, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993 ; 69: 236.
20. Dale J., Myhre E., Loew D. Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement. Am Heart J 1980 ; 99: 746.
21. Chesebro J., Fuster V., Elveback L., et al. Trial of combined warfarin plus dipyridamole or aspirin in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole. Am J Cardiol 1983 ; 51: 1537.
22. Meschengieser SS, Fondevila CG, Sntarelli MT, et al. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: A randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovac Surg 1997 ; 113: 910.
23. Palareti G., Leali N., Coccheri S., et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaboratory study (ISCOAT). Lancet 1996 ; 348: 423.
24. Albertal J., Sutton M., Pereyra D., et al. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement: A retrospective nonrandomized study. J Heart Valve Dis 1993 ; 2: 302.
25. Lafford P., Boudaut R., Roques X., et al. Early- and long-term (one year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with St Jude Medical prosthesis: A clinical and transesophageal echocardiographic study. J Am Coll Cardiol 2000 ; 35: 739.
26. Horstkotte D., Shulte Iid, Bircks W., Strauer BE Lower intensity anticoagulation therapy results in lower complication rates with the St Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994 ; 107: 1136.
27. Horstkotte D., Bergemann R., Althaus U., et al. German experience with low intensity anticoagulation (GELIA): Protocol of a multicenter randomized prospective study with the St Jude Medical valve. J Heart Valve Dis 1993 ; 2: 411.
28. David TE, Gott VL, Harker LA Mechanical valves. Ann Thorac Surg 1996 ; 62: 1567.
29. Goldsmith I., Lyp GY, Patel RL Evaluation of the Sorin bi-carbon bileaflet valve in 488 patients (519 prostheses). Am J Cardiol 1999 ; 83: 1069.